{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,4]],"date-time":"2026-07-04T05:20:14Z","timestamp":1783142414892,"version":"3.54.6"},"reference-count":18,"publisher":"Japanese Society for Lymphoreticular Tissue Research","issue":"2","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["JCEH","J Clin Exp Hematopathol"],"published-print":{"date-parts":[[2026]]},"DOI":"10.3960\/jslrt.26006","type":"journal-article","created":{"date-parts":[[2026,6,27]],"date-time":"2026-06-27T22:11:03Z","timestamp":1782598263000},"page":"136-141","source":"Crossref","is-referenced-by-count":0,"title":["Synchronous diffuse large B-cell lymphoma and gynecological malignancy treated with paclitaxel and carboplatin: A report of two cases"],"prefix":"10.3960","volume":"66","author":[{"given":"Yuma","family":"Nato","sequence":"first","affiliation":[{"name":"Department of Hematological Malignancies, Mie University Graduate School of Medicine, Tsu, Japan,"},{"name":"Department of Hematology and Oncology, Mie University Graduate School of Medicine, Tsu, Japan,"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kana","family":"Miyazaki","sequence":"additional","affiliation":[{"name":"Department of Hematology and Oncology, Mie University Graduate School of Medicine, Tsu, Japan,"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tsuyoshi","family":"Matsumoto","sequence":"additional","affiliation":[{"name":"Department of Obstetrics and Gynecology, Mie University Graduate School of Medicine, Tsu, Japan,"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kota","family":"Okamoto","sequence":"additional","affiliation":[{"name":"Department of Obstetrics and Gynecology, Mie University Graduate School of Medicine, Tsu, Japan,"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yasuhiro","family":"Teishikata","sequence":"additional","affiliation":[{"name":"Department of Obstetrics and Gynecology, Kuwana City Medical Center, Kuwana, Japan,"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Akihide","family":"Nakamura","sequence":"additional","affiliation":[{"name":"Department of Hematology and Oncology, Mie University Graduate School of Medicine, Tsu, Japan,"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hiroshi","family":"Imai","sequence":"additional","affiliation":[{"name":"Pathology Division, Mie University Hospital, Tsu, Japan,"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Takashi","family":"Watanabe","sequence":"additional","affiliation":[{"name":"Department of Personalized Control Science of Myeloid and Lymphoid Tumors, Mie University Graduate School of Medicine, Tsu, Japan"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Isao","family":"Tawara","sequence":"additional","affiliation":[{"name":"Department of Hematology and Oncology, Mie University Graduate School of Medicine, Tsu, Japan,"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Motoko","family":"Yamaguchi","sequence":"additional","affiliation":[{"name":"Department of Hematological Malignancies, Mie University Graduate School of Medicine, Tsu, Japan,"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"2349","reference":[{"key":"1","doi-asserted-by":"crossref","unstructured":"1 Vogt A, Schmid S, Heinimann K <i>et al.<\/i> Multiple primary tumours: challenges and approaches, a review. ESMO Open. 2017; 2: e000172.","DOI":"10.1136\/esmoopen-2017-000172"},{"key":"2","doi-asserted-by":"crossref","unstructured":"2 Pan SY, Huang CP, Chen WC. Synchronous\/Metachronous Multiple Primary Malignancies: Review of Associated Risk Factors. Diagnostics (Basel). 2022; 12: 1940.","DOI":"10.3390\/diagnostics12081940"},{"key":"3","doi-asserted-by":"crossref","unstructured":"3 Zhai C, Cai Y, Lou F <i>et al.<\/i> Multiple Primary Malignant Tumors - A Clinical Analysis of 15,321 Patients with Malignancies at a Single Center in China. J Cancer. 2018; 9: 2795-2801.","DOI":"10.7150\/jca.25482"},{"key":"4","unstructured":"4 Osajima Y, Sawabe M, Hashimoto R <i>et al.<\/i> [Analysis of multiple cancers in autopsy cases of elderly hematological malignancies]. Rinsho Ketsueki. 2008; 49: 1599-1603."},{"key":"5","doi-asserted-by":"crossref","unstructured":"5 Ozcivit Erkan IB, Kuru O, Turker Saricoban C <i>et al.<\/i> Unusual synchronous and metachronous association of hematologic neoplasms with gynecologic neoplasms: A case series and literature review. Int J Gynaecol Obstet. 2025; 169: 1025-1036.","DOI":"10.1002\/ijgo.16075"},{"key":"6","doi-asserted-by":"crossref","unstructured":"6 Kostopoulos IS, Barbanis SB, Kaloutsi VD, Papadimitriou CS. Synchronous occurrence of multiple malignant neoplasms in the uterus (adenocarcinoma of the endometrium, large B-cell lymphoma of the cervix). Pathol Res Pract. 2000; 196: 573-575.","DOI":"10.1016\/S0344-0338(00)80030-8"},{"key":"7","doi-asserted-by":"crossref","unstructured":"7 Singhal N, Quilty S, George M, Davy M, Selva Nayagam S. A tale of two cancers: collision presentation of ovarian carcinoma and lymphoma. Aust N Z J Obstet Gynaecol. 2009; 49: 232-234.","DOI":"10.1111\/j.1479-828X.2009.00974.x"},{"key":"8","doi-asserted-by":"crossref","unstructured":"8 Gupta R, Dave P, Patel B, Shukur RA. A Rare Occurrence of Solid Gynecological Malignancy Synchronous with Hematological Malignancy: Rare Case and Review of Literature. Indian J Med Paediatr Oncol. 2024; 45: 439-442.","DOI":"10.1055\/s-0043-1775830"},{"key":"9","doi-asserted-by":"crossref","unstructured":"9 Miyazaki K, Yamaguchi M, Suzuki R <i>et al.<\/i> CD5-positive diffuse large B-cell lymphoma: a retrospective study in 337 patients treated by chemotherapy with or without rituximab. Ann Oncol. 2011; 22: 1601-1607.","DOI":"10.1093\/annonc\/mdq627"},{"key":"10","doi-asserted-by":"crossref","unstructured":"10 Miyazaki K, Asano N, Yamada T <i>et al.<\/i> DA-EPOCH-R combined with high-dose methotrexate in patients with newly diagnosed stage II-IV CD5-positive diffuse large B-cell lymphoma: a single-arm, open-label, phase II study. Haematologica. 2020; 105: 2308-2315.","DOI":"10.3324\/haematol.2019.231076"},{"key":"11","unstructured":"11 Okamoto M: Dexamethasone, Etoposide, Ifosfamide and Carboplatin (DeVIC): An effective salvage treatment for intermediate or high grade non-Hodgkin\u2019s lymphoma (NHL). A multicenter study. Proc ASCO 13. 1994; pp. 376."},{"key":"12","doi-asserted-by":"crossref","unstructured":"12 Gopal AK, Press OW, Shustov AR <i>et al.<\/i> Efficacy and safety of gemcitabine, carboplatin, dexamethasone, and rituximab in patients with relapsed\/refractory lymphoma: a prospective multi-center phase II study by the Puget Sound Oncology Consortium. Leuk Lymphoma. 2010; 51: 1523-1529.","DOI":"10.3109\/10428194.2010.491137"},{"key":"13","doi-asserted-by":"crossref","unstructured":"13 Gisselbrecht C, Glass B, Mounier N <i>et al.<\/i> Salvage regimens with autologous transplantation for relapsed large B-cell lymphoma in the rituximab era. J Clin Oncol. 2010; 28: 4184-4190.","DOI":"10.1200\/JCO.2010.28.1618"},{"key":"14","doi-asserted-by":"crossref","unstructured":"14 Wu L, Wang J, Li Y <i>et al.<\/i> Development of taxane-containing chemotherapy of doxorubicin-resistant diffuse large B-cell lymphoma. Anticancer Drugs. 2014; 25: 826-831.","DOI":"10.1097\/CAD.0000000000000067"},{"key":"15","doi-asserted-by":"crossref","unstructured":"15 Luo B, Gu YY, Wang XD, Chen G, Peng ZG. Identification of potential drugs for diffuse large b-cell lymphoma based on bioinformatics and Connectivity Map database. Pathol Res Pract. 2018; 214: 1854-1867.","DOI":"10.1016\/j.prp.2018.09.013"},{"key":"16","doi-asserted-by":"crossref","unstructured":"16 Hong H, Luo B, Qin Y, Li S, Peng Z. RNA-seq and integrated network analysis reveals the hub genes and key pathway of paclitaxel inhibition on Adriamycin resistant diffuse large B cell lymphoma cells. Bioengineered. 2022; 13: 7607-7621.","DOI":"10.1080\/21655979.2022.2048772"},{"key":"17","doi-asserted-by":"crossref","unstructured":"17 Wilson WH, Chabner BA, Bryant G <i>et al.<\/i> Phase II study of paclitaxel in relapsed non-Hodgkin\u2019s lymphomas. J Clin Oncol. 1995; 13: 381-386.","DOI":"10.1200\/JCO.1995.13.2.381"},{"key":"18","doi-asserted-by":"crossref","unstructured":"18 Younes A, Sarris A, Melnyk A <i>et al.<\/i> Three-hour paclitaxel infusion in patients with refractory and relapsed non-Hodgkin\u2019s lymphoma. J Clin Oncol. 1995; 13: 583-587.","DOI":"10.1200\/JCO.1995.13.3.583"}],"container-title":["Journal of Clinical and Experimental Hematopathology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.jstage.jst.go.jp\/article\/jslrt\/66\/2\/66_26006\/_pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,7,4]],"date-time":"2026-07-04T05:12:44Z","timestamp":1783141964000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.jstage.jst.go.jp\/article\/jslrt\/66\/2\/66_26006\/_article"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026]]},"references-count":18,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2026]]}},"URL":"https:\/\/doi.org\/10.3960\/jslrt.26006","relation":{},"ISSN":["1346-4280","1880-9952"],"issn-type":[{"value":"1346-4280","type":"print"},{"value":"1880-9952","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026]]},"article-number":"26006"}}